Marimed (MRMD) Preferred Stock Liabilities (2020 - 2026)

Marimed (MRMD) has 7 years of Preferred Stock Liabilities data on file, last reported at $6.9 million in Q1 2026.

• On a quarterly basis, Preferred Stock Liabilities fell 52.92% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 52.92% decrease from a year earlier, with the FY2025 full-year figure at $14.7 million, down 22.5% from the prior year.
• Preferred Stock Liabilities for Q1 2026 stood at $6.9 million, down from $14.7 million in the prior quarter.
• Over the last five years, Preferred Stock Liabilities for MRMD reached as high as $37.7 million in Q1 2022 and fell as low as $6.9 million in Q1 2026.
• Historically, Preferred Stock Liabilities has averaged $23.0 million across 5 years, with a median of $19.0 million in 2023.
• Across the five-year window, Preferred Stock Liabilities changed 0.0% in 2022 and sank 52.92% in 2026, its largest moves.
• Year by year, Preferred Stock Liabilities stood at $37.7 million in 2022, then tumbled by 49.64% to $19.0 million in 2023, then changed by 0.0% to $19.0 million in 2024, then retreated by 22.5% to $14.7 million in 2025, then slumped by 52.92% to $6.9 million in 2026.
• Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $6.9 million in Q1 2026, $14.7 million in Q4 2025, and $14.7 million in Q3 2025.